Business Context and Reporting Period
Company: Mativ Holdings, Inc. (formerly Schweitzer-Mauduit International, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: December 23, 2022
Event: Entry into a Material Definitive Agreement regarding an accounts receivable securitization facility.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or existing debt levels. The primary financial metric disclosed is the capacity of a new financing arrangement:
- New Liquidity Facility: Accounts Receivable (A/R) Securitization Facility.
- Aggregate Principal Amount: Up to $175.0 million.
- Facility Termination Date: December 23, 2025.
- Purpose: To provide additional liquidity and funding for ongoing business needs.
Material Changes
The material change reported is the establishment of the A/R Facility on December 23, 2022. Key structural details include:
- Structure: The Company and certain subsidiaries (Originators) sell/contribute accounts receivable to a wholly-owned, bankruptcy-remote indirect subsidiary (Mativ Receivables, LLC, the "Seller").
- Securitization: The Seller sells these receivables to Purchasers in exchange for payment.
- Guarantees: The Company provides a customary guaranty of performance for the Originators' obligations but explicitly does not guarantee the payment of the Seller's obligations or the creditworthiness of the obligors.
- Costs: The Seller pays a Yield Rate and customary monthly fees to Purchasers.
Outlook, Risks, and Contingencies
Management Commentary: The facility is intended to support ongoing business needs through 2025.
Risks and Contingencies: The agreements contain customary events of default, which may include provisions for the acceleration of amounts owed by the Seller to the Purchasers upon the occurrence of certain events. The filing incorporates the full terms of the Receivables Purchase Agreement and Sale and Contribution Agreement by reference.
Investor Verification Checklist
- Review the full text of the Receivables Purchase Agreement (Exhibit 10.1) and Sale and Contribution Agreement (Exhibit 10.2) for specific covenants and default triggers.
- Verify the specific Yield Rate and fee structure applicable to the facility, as exact percentages are not disclosed in the summary text.
- Confirm the impact of this facility on the Company's consolidated balance sheet and leverage ratios in subsequent quarterly filings.
- Monitor the utilization rate of the $175.0 million facility to assess liquidity management strategies.